Studies showed that in vitro treatment of miR-146a may induce the expression of proinflammatory factors such as TNF-α, NF-κB p65, and MCP-1, which are essential transcription factors in atherosclerosis [13]. This evidence concerns the gene CCL2 and atherosclerosis.